A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation

International Immunology

Volumn 13, Issue 5, 2001, Pages 657-664

  Makar, Karen W ^a,c   Ulgiati, Daniela ^a   Hagman, James ^b   Holers, V Michael ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

B lymphocytes; CBF1; Cellular differentiation; Complement; Gene regulation; Transcription factors

Indexed keywords

COMPLEMENT RECEPTOR; NOTCH RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; TRANSCRIPTION REGULATION;

EID: 0035003073     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/13.5.657     Document Type: Article

References (40)

1. The CD19/CD21 signal transduction complex of B lymphocytes
2. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2
3. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen
4. -/- mice restores humoral immune function
5. Dependence of germinal center B cells on expression of CD21/CD35 for survival
6. Mouse complement receptors type 1 (CR1; CD35) and type 2 (CR2; CD21): Expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice
7. Expression of C3d receptors during human B cell differentiation: Immunofluorescence analysis with the HB-5 monoclonal antibody
8. Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection
9. Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of development arrest
10. Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death
11. An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene
12. Epstein-Barr virus (EBV) nuclear antigen 2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context
13. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23
14. Notch signaling
15. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages
16. Notch activity influences the αβ versus γδ T cell lineage decision
17. Regulation of T cell fate by Notch
18. Notch 1 expression in early lymphopoiesis influences B versus T lineage determination
19. Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-Jκ
20. Functional replacement of the intracellular region of the Notch1 receptor by Epstein-Barr virus nuclear antigen 2
21. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2
22. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter
23. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene
24. Purification of a novel MHC class I element binding activity from thymus nuclear extracts reveals that thymic RBP-Jκ/CBF1 binds to NF-κB-like elements
25. Identity of the β-globin locus control region binding protein HS2NF5 as the mammalian homolog of the Notch-regulated transcription factor Suppressor of Hairless
26. Loss of immunostaining of the RBP-Jκ transcription factor upon F9 differentiation induced by retinoic acid
27. A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development
28. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1
29. Constitutively active human Notch1 binds to the transcription factor CBF1 and stimulates transcription through a promoter containing a CBF1-responsive element
30. Developmental expression of Sp1 in the mouse
31. Transcriptional regulation during B cell development
32. Suppressor of Hairless, the Drosophila homolog of the mouse recombination signal-binding protein gene, controls sensory organ cell fates
33. 2 transactivation by recombination signal-binding protein Jκ
34. Rel/NF-κB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors
35. Notch2: A second mammalian Notch gene
36. Epstein-Barr virus immortilization: Notch2 interacts with CBF1 and blocks differentiation
37. Expression of the murine CD21 gene is regulated by promoter and intronic sequences
38. Lymphoid transcription of the murine CD21 gene is positively regulated by histone acetylation
39. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway
40. CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex